Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 2:12:858151.
doi: 10.3389/fonc.2022.858151. eCollection 2022.

A high preoperative serum IL-25 level is a negative prognosis predictor after liver resection for HBV-HCC

Affiliations

A high preoperative serum IL-25 level is a negative prognosis predictor after liver resection for HBV-HCC

Shao-Hua Chen et al. Front Oncol. .

Abstract

Objective: The aim of this study was to evaluate the association between preoperative IL-25 levels and HBV-HCC patient outcomes following liver surgery.

Methods: This study enrolled consecutive HCC patients that had undergone liver surgery from 2008 to 2015. Baseline patient clinical properties were assessed to establish predictors of postoperative overall survival and recurrence-free survival (OS and RFS, respectively) following liver resection. In addition, serum IL-25 levels were assessed via ELISA.

Results: Cox regression analyses revealed IL-25 levels to be independently related to the OS and RFS of 896 HBV-associated HCC patients. An optimal IL-25 cutoff level of 14.9 μg/ml was identified, with 206 patients in this cohort having IL-25 levels above this threshold. Both the OS and RFS of patients with an IL-25 level <14.9 μg/ml were significantly better after liver resection as compared to those of patients with higher preoperative levels of this cytokine (p < 0.05). Cox multivariate regression analyses revealed an IL-25 level ≥ 14.9 μg/L to be an independent predictor of poorer RFS and OS. A combination of IL-25 levels and tumor diameter may be an even more reliable predictor of OS.

Conclusions: IL-25 levels are independent predictors of postoperative survival within HCC patients undergoing liver resection.

Keywords: IL-25; biomarker; hepatitis B virus; hepatocellular carcinoma; prognosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Study population selection.
Figure 2
Figure 2
Assessments of the receiver operating characteristic (ROC) curve for the specificity and sensitivity of IL-25 in HCC patients.
Figure 3
Figure 3
(A, B) RFS (A) and OS (B) curves for all 896 HCC patients with low or high IL-25 levels. (C) Curves of RFS for HCC patients in the PSM cohort with low or high IL-25 levels. (D) Curves of OS for HCC patients in the PSM cohort with low or high IL-25 levels.
Figure 4
Figure 4
HCC patient survival nomogram. (A, B) A survival nomogram designed to assess HCC patient RFS (A) and OS (B).

Similar articles

Cited by

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin (2018) 68(6):394–424. doi: 10.3322/caac.21492 - DOI - PubMed
    1. Dechassa ML, Tryndyak V, de Conti A, Xiao W, Beland FA, Pogribny IP. Identification of chromatin-accessible domains in non-alcoholic steatohepatitis-derived hepatocellular carcinoma. Mol Carcinog (2018) 57(8):978–87. doi: 10.1002/mc.22818 - DOI - PubMed
    1. Cheng Z, Lei Z, Yang P, Si A, Xiang D, Tang X, et al. . Exosome-transmitted p120-catenin suppresses hepatocellular carcinoma progression via STAT3 pathways. Mol Carcinog (2019) 58(8):1389–99. doi: 10.1002/mc.23022 - DOI - PubMed
    1. Zhang N, Zhang S, Wu W, Lu W, Jiang M, Zheng N, et al. . Regorafenib inhibits migration, invasion, and vasculogenic mimicry of hepatocellular carcinoma via targeting ID1-mediated EMT. Mol Carcinog (2021) 60(2):151–63. doi: 10.1002/mc.23279 - DOI - PubMed
    1. Bao Y, Suvesh M, Li X, Bai X, Li H, Li X, et al. . Ebp1 p48 promotes oncogenic properties in hepatocellular carcinoma through p38 MAPK/HIF1α activation and p53 downregulation. Mol Carcinog (2021) 60(4):252–64. doi: 10.1002/mc.23288 - DOI - PubMed

LinkOut - more resources